Bris­tol My­ers launch­es pro­gram to make clin­i­cal tri­als more ac­ces­si­ble for peo­ple with dis­abil­i­ties

About a fourth of US adults live with some type of dis­abil­i­ty, ac­cord­ing to the CDC. On Wednes­day, Bris­tol My­ers Squibb launched a new ini­tia­tive to en­sure those pa­tients get ac­cess to clin­i­cal tri­als.

The phar­ma gi­ant is team­ing up with the non­prof­it Dis­abil­i­ty So­lu­tions to cre­ate the Dis­abil­i­ty Di­ver­si­ty in Clin­i­cal Tri­als (DDiCT) Ini­tia­tive, a pro­gram that’s ini­tial­ly fo­cus­ing on com­ing up with a set of rec­om­men­da­tions for im­prov­ing ac­cess, speed of en­roll­ment and par­tic­i­pa­tion of peo­ple with dis­abil­i­ties in tri­als.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.